The effect of insulin secretion due to oral glucose consumption is higher than intravenous glucose infusion and is called the “incretin effect.” Two incretin hormones, glucagon-like peptide and glucose-dependent insulinotropic polypeptide, have been studied more in recent years due to their glucose-lowering effects for T2DM. This evidence concerns the gene GCG and type 2 diabetes mellitus.